Premium Only Content
This video is only available to Rumble Premium subscribers. Subscribe to
enjoy exclusive content and ad-free viewing.

Alzheimer's Therapy Drug: Should We Pay $56,000 to Slow the Loss of Mom's Mind?
4 years ago
1.04K
Aduhelm sparks controversy as a therapy drug for Alzheimer's patients that attacks amyloid plaques in the brain, and slows the decline of memory and problem-solving by about 25% over time. It's not a cure, and it can't even restore lost mental capabilities. Now that the FDA has fast-tracked approval, should American taxpayers cover the $56,000/year per patient cost for relative minor results?
Scott Ott, Stephen Green and Bill Whittle create 240 new episodes of Right Angle annually, thanks to our Members. Join us now at https://BillWhittle.com
Loading 19 comments...
-
16:40
Bill Whittle: Conservative Opinion | Humor
25 days ago $4.23 earnedCleaning Up D.C.
2.94K6 -
1:21:51
TheDAMpodcast
4 years ago $0.06 earnedWhen and why should anyone take therapy?
1081 -
3:56
NEWSMAX
4 years agoFDA APPROVES NEW ALZHEIMER'S DRUG
1.9K23 -
1:11
IOL-IndependentOnline
4 years ago $0.01 earnedFirst patient receives controversial Biogen Alzheimer's drug
37 -
1:56
KGUN
4 years agoHikers should keep heat safety in mind
2 -
1:46:28
Badlands Media
22 hours agoAltered State S3 Ep. 45: The Assassination of Charlie Kirk
139K19 -
8:56:53
Dr Disrespect
15 hours ago🔴LIVE - DR DISRESPECT - THE FINALS - NEW SEASON 8 LAUNCH EVENT W/ THE SHOTTY BOYS
268K10 -
LIVE
RealAmericasVoice
3 days agoHOME OF REAL NEWS
3,237 watching -
27:00
BonginoReport
9 hours agoRest In Peace Charlie Kirk - Nightly Scroll w/ Hayley Caronia (Ep.131) - 09/10/2025
252K388 -
1:20:06
Kim Iversen
10 hours agoRIP Charlie Kirk: When Words Fail, They Reach for Guns
179K326